SEC Filing Update: #HBIO Harvard Bioscience, Inc. : $7.96

Sector: Healthcare | YTD: 🔼+ 22.10% The SEC disclosed Today (22-SEP-2026) that LEVITICUS PARTNERS L P has DECREASED #HBIO Shares by -19.98% 🔴 * Previous Holdings: 293.68K Shares * Current Holdings: 235.00K Shares * Decrease -58.68K * Decreased (%)-19.98% * Ownership: 5.2% https://www.thinksabio.com/reports/isr/HBIO Institutional ownership in #HBIO has been steadily rising over the past 2 quarters in Shares: Q1 2026: 1.59M Q2 2026: 1.62M The quarterly average prices of #HBIO: Q2 2026: $6.00 📈 Stay ahead of institutional buy/sell moves — Sign up free at ThinkSabio: Sign Up Free → 🐦 See this update on X: https://x.com/Thinksabio/status/2102405626177425708 Leviticus Partners L.P. reduced its stake in HBIO by 58,676 shares, from 293,676 to 235,000 shares, maintaining a 5.2% ownership position in the healthcare company.